An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
Clinical trial NCT06991556 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06991556
- Sponsor
- Novartis Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-07
- Primary completion
- 2032-02-13
- Enrollment
- 165
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.